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Our aim was to measure the adherence to Artemisinin based Combination Therapy and to determine patient related factors that
affect adherence.Three hundred (300) patients receiving ACT treatment dispensed from the community pharmacy were randomly
selected and followed up on the fourth day after the start of their three-day therapy to assess adherence. Adherence was measured
by pill count. Quantitative interviews using a semistructured questionnaire were used to assess patients’ knowledge and beliefs on
malaria and its treatment. Adherence levels to the ACTs were 57.3%. Patient related factors that affected adherence to ACTs were
patients’ knowledge on the dosage (𝑃 = 0.007; V = 0.457), efficacy (𝑃 = 0.009; V = 0.377), and side effects (𝑃 = 0.000; V = 0.403) of
the ACTs used for the management of malaria, patients’ awareness of the consequences of not completing the doses of antimalarial
dispensed (𝑃 = 0.001; V = 0.309), and patients’ belief that “natural remedies are safer than medicines” and “prescribers place too
much trust in medicines.” There was no significant relationship between adherence and patients’ knowledge on the causes, signs,
and symptoms ofmalaria.There is the need for pharmacy staff to stress on these variables when counseling patients on antimalarials
as these affect adherence levels.
1. Introduction
Malaria is still a concern in most developing countries in
Africa. Although, in 2010, malaria caused 660,000 deaths
mostly among African countries, malaria mortality rates are
gradually falling and have reduced by more than 33% in
Africa [1]. In Ghana, about 32.5% of all outpatient attendance
and 48.8% admissions of children under the age of 5 are due
to malaria [2]. For decades, chloroquine (CQ) was used as
first-line treatment formalaria inmany developing countries,
including Ghana. However, its use has become limited due
to the emergence of resistance and subsequent treatment
failure. Factors which may have contributed to chloroquine
treatment failures include incorrect dosing, noncompliance
with duration of the dosing regimen, poor drug quality, drug
interaction, and misdiagnosis [3].
Over the past few years, a new group of antimalar-
ials, the Artemisinin Based Combination Therapy (ACT)
compounds, found to produce a very rapid therapeutic
response have been introduced. These medicines are active
against multidrug resistant Plasmodium falciparum [4]. In
line with World Health Organization (WHO) recommen-
dations, nearly all high-burden African countries including
Ghana have moved from chloroquine to ACTs as first-line
treatment. In 2008, therewere reports at theThai-Cambodian
border that the ACTs were losing their potency [5]. This
is further backed by a study in Parlin, western Cambodia,
which indicates that some resistance has been developed
towards the ACTs [6]. WHO also acknowledges the fact
that rational uses of antimalarial medicines are critical; it
suggests that resistance to the ACTs could unravel national
malaria control programmes [7]. Currently, ACTs are the only
recommended antimalarial medicines for uncomplicated
malaria in many developing countries like Ghana; hence
caution should be taken to ensure its rational use to curtail
the emergence of resistance in the near future [8]. It is also
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important that suggested ways of preventing antimalarial
resistance are followed. These include more selective use of
drugs and improved prescribing practices and strategies to
improve patient adherence. Such interventions must also be
continually monitored and assessed [3]. Adherence refers to
the extent to which patients follow through decisions about
medicine taking [9]. A number of studies have focused on
assessing patient adherence to antimalarials and some factors
associated with adherence. Adherence levels (based on pill
count) are estimated to be between 40% and 70% [10, 11].
Attendance to a particular health center and instructions not
to give medication to another person and to return if fever
persists are some factors associated with complete adherence.
Others are taking the first dose at the health centre, a
preference forArtemether Lumefantrine (AL) comparedwith
other antimalarials and patients’ knowledge with respect to
the ACT dosage regimen [10–12].
The Affordable Medicines Facility for Malaria (AMFM)
initiated in Ghana may have led to an expansion of ACTs
for the management of malaria as they are easily available
and affordable [13]. Measures should therefore be taken to
ensure and monitor its rational use to avoid the emergence
of resistance. Research data assessing patient related factors
that affect adherence to antimalarial medication are scanty.
Searching through the literature, only few studies were iden-
tified which explored adherence and patients’ knowledge on
some aspects of malaria and its treatment. There is therefore
the need to address this knowledge gap so that health care
practitioners may be informed on which facts onmalaria and
its treatments the patient should be verymuch aware of when
antimalarials are prescribed and dispensed.
Aim of the Study. It is to explore patient’s knowledge and
beliefs on malaria and its treatment and how it affects
adherence.
2. Methodology
2.1. Ethical Considerations. Permission for the research was
sought and granted by the Robert Gordon University Ethical
Committee and the Committee onHuman Research Publica-
tions and Ethics, Kwame Nkrumah University of Science and
Technology, School of Medical Sciences, and Komfo Anokye
Teaching Hospital, Kumasi, Ghana.
2.2. Study Area and Sample. The study was conducted in a
community pharmacy situated in Lakeside Estate, a suburb
of Accra, the capital of Ghana. The community pharmacy
setting was chosen because it is one of the common pri-
mary health facilities where malaria is managed. In Ghana,
ACTs are commonly prescribed by many of the health care
personnel working in different health care settings. However
physicians practising hospitals and health centres normally
prescribe ACTs. Pharmacists practising in the community
pharmacy may also prescribe ACTs if a patient presents
with signs and symptoms consistent with malaria and it is
confirmed using a Rapid Diagnostic Test (RDT) kit. Our
inclusion criteria were patients to whom ACTs have been
prescribed by any of these health care practitioners and
dispensed from the community pharmacy. Patients aged 0–17
years and patients with no contact numbers were excluded.
The sample size required was calculated according to the
formula 𝑛 = 𝑡2 × 𝑝(1 − 𝑝)/𝑚2 (𝑡 = confidence level at 95%;
margin of error at 5%; 𝑝 = estimated prevalence of 30%).
From this equation a sample of 277 was obtained. However,
the sample was further increased by 5% to account for
contingencies. A total of 356 subjects were recruited for the
study.
2.3. Development and Validation of Questionnaire. A
semistructured questionnaire was designed for a face-to-face
interview with the patient with reference to the Beliefs and
Behaviour Questionnaire (BBQs), knowledge attributes and
practices questionnaire (KAP) [14, 15], and literature on the
causes, signs, symptoms, and management of uncomplicated
malaria. Two community pharmacists and an academic
pharmacist face validated the semistructured questionnaire.
The questionnaire was further retested to ensure its reliability.
There is no standard method for measuring adherence [16].
Methods available such as electronic prescribing and patient
self-report both have certain faults, and hence some authors
suggest that more than one method for measuring adherence
should normally be used [16, 17]. Although certain methods
of measuring adherence may be preferred in specific
clinical or research settings, a combination of measures
maximizes accuracy [17]. This is because it helps to derive
the advantages of the two methods used. Hence ideally, one
self-report measure and electronic prescribing (Medication
Event Monitoring System, MEMS) should be used for the
study. Medication Event Monitoring System (MEMS) could
have been very appropriate for the study. The medication
bottle has a cap containing a microprocessor which records
date and time of all the opening. However, the MEMS
method cannot be applied to this study although it would
have added to the reliability of the study because it is not
available in Ghana. In most researches that have studied the
adherence to antimalarials with respect to malaria and its
treatment, pill count was the only adherence measure used
[10–12]. Hence in our study, pill count was used to explore
adherence to the ACTs.
2.4. Data Collection. Data was collected over a period of
five months, from April 1, 2013, to August 31, 2013. Five
randomly selected patients fitting into the inclusion criteria
were recruited every day from Tuesday to Thursday and
follow-ups were from Friday toMonday. Consent was sought
before recruitment. On the day of recruitment patients were
educated on the causes, signs, symptoms, and prevention of
malaria. They were also educated on the name, dosage, side
effects and efficacy of the antimalarial dispensed, cautionary
measures to observe while taking their antimalarial, and
consequences of not completing their antimalarial dosages
before antimalarials were dispensed. On the fourth day after
the three-day therapy, patients were followed up to assess
adherence. Adherence was assessed by pill counting of anti-
malarial packs. Furthermore, a face-to-face interview with
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Table 1: Adherence to ACTs.
ACTs Adherent Partially adherent Nonadherent Total
Artemether/Lumefantrine (AL) 135 (61.6) 67 (30.6) 17 (7.8) 219
Artesunate/Amodiaquine (AA) 25 (45.4) 14 (25.4) 16 (29.1) 55
Artesunate/piperazine (AP) 12 (46.1) 8 (30.7) 6 (23.0) 26
300
the semistructured questionnaire was used to assess respon-
dents’ beliefs on malaria and knowledge on the causes, signs,
symptoms, and treatment of malaria. It was the researcher
and other trained data collectors who collected the data.
The recommended ACTs considered included Artesunate
Amodiaquine (AA), Artemether Lumefantrine (AL), and
Dihydroartemisinin Piperaquine (DP).
2.5. Data Analysis. SPSS version 17was used for data analysis.
To measure the level of adherence to antimalarial medica-
tion based on pill count, the number of tablets taken was
converted into percentages and defined as follows: 100% fully
adherent; 70%–<100% partially adherent; <70% nonadherent
[9]. 𝑃 values obtained by comparing patient’s knowledge
scores and adherence were said to be significant if 𝑃 value
was less than 0.05. Cramer’s𝑉 test was used to determine the
strength of the association; values of 0–0.30 were considered
as weak, 0.31–0.70 as moderate, and 0.71–1.0 as strong.
To determine respondents’ knowledge score on the causes,
symptoms, and prevention of malaria, a scoring system
was employed where patients were given a score on each
correct answer provided for causes, symptoms, prevention of
malaria, with a total of 5 marks being awarded. With regard
to respondents’ knowledge on treatment of malaria, a scoring
system was also used, where respondents were given a mark
for each correct answer on the following variables: name
of the prescribed ACTs; dosage of the ACTs; precaution to
observe while taking the ACTs; any side effects of the ACTs;
efficacy of the ACTs; and consequences of untreated malaria.
3. Results
Three hundred and fifty-six (356) participants were recruited
for the study and 56 were lost to follow-up.
3.1. Antimalarial Dispensed and Adherence to Antimalarial
Medication. Two hundred and nineteen respondents (73.0%)
dispensed AL, 55 (18.3%) AA, and 26 (8.7%) AP (Table 1).
Based on the pill count assessment 172 (57.33%) respondents
were adherent.
3.2. Knowledge on Causes, Signs, Symptoms, and Prevention
of Malaria and Its Effects on Adherence. All three hundred
(100%) respondents had heard of malaria. Modes of trans-
mission of malaria cited included mosquito bite 296 (98.7%),
weather 2 (0.67%), and evil spirit 1 (0.33%). One hundred
(57.3%) respondents were aware of headache, body pains,
fever, and loss of appetite as common signs and symptoms
of malaria. Two hundred and five (68.3%) respondents knew
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Figure 1: The relationship between adherence and patients’ knowl-
edge score on medicines prescribed for antimalarial.
three methods for the prevention of malaria. These were the
use of bed nets, mosquito spray, repellents, and mosquito
coil. The mean patients knowledge score on causes, signs,
symptoms, and prevention of malaria was 3.18 (SD = 0.852)
out of 5. The 𝑃 and Cramer’s 𝑉 values obtained for the rela-
tionship between adherence and patient overall knowledge
on the causes, signs, symptoms, and prevention of malaria
were chi square: 12.467; df = 8; 𝑃 = 0.132; 𝑉 = 0.144.
3.3. Knowledge on Treatment ofMalaria and Its Relationship to
Adherence. Twenty-seven (56.3%) respondents out of the 48
respondents that had average knowledge on the treatment of
malaria were adherent, 15 (31.30%) partially adherent, and 6
(12.50%) nonadherent (Figure 1). Two hundred and seventy
(89.4%) respondents agreed that the ACTs were effective.
Two hundred and twenty-one respondents (73.2%) indicated
that the ACTs did not have side effects, while 79 (26.2%)
respondents said the ACTs have side effects (Table 2). Side
effects cited included nausea 76 (96.2%), vomiting 78 (98.7%),
and dizziness 66 (83.5%). Precautions to observe while
taking their antimalarial medication cited by respondents
included taking medicine after food 44 (14.7%), finishing all
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Table 2: Knowledge on treatment of malaria and its relationship to adherence.
Respondents awareness 𝑁 Adh Par Adh Non Adh 𝑃 value 𝑉
The name ACTs recommended for the
management of malaria 264 (88%) 157 73 34 0.910 0.126
Dosage of ACTs recommended for the
management of malaria 252 (86%) 160 65 40 0.007 0.457
Efficacy of antimalarial 269 (89%) 162 76 31 0.009 0.377
Side effects of antimalarial 79 (26%) 31 30 18 0.000 0.403
Cautionary and advisory measures to
observe while taking antimalarial 268 (89%) 162 74 32 0.456 0.110
The consequences of not completing the
doses of antimalarial dispensed 272 (90%) 161 77 34 0.001 0.309
∗Adh: adherent; ∗Par Adh: partially adherent; ∗Non Adh: nonadherent; 𝑉: Cramer’s 𝑉.
medications 60 (20.0), and taking them as directed 107
(35.7%). Two hundred and seventy-two (90.1%) respondents
knew malaria can kill if untreated. The mean patient’s
knowledge score on treatment of malaria was 4.0867 out
of 6 (SD = 1.069). The 𝑃 and Cramer 𝑉’s values obtained
for the relationship between adherence and patients’ overall
knowledge on the ACTs used for the treatment ofmalaria was
(chi square: 30.354; df = 12; 𝑃 = 0.002; 𝑉 = 0.325).
3.4. Beliefs on Malaria and Its Relationship to Adherence.
Eighty-four (28.2%) respondents agreed that prayers, instead
of medicines taken, healed them frommalaria. One hundred
and fifty-one (50.3%) respondents felt that prescribers place
toomuch trust onmedicines and that if prescribers hadmore
time with patients they would prescribe fewermedicines.The
𝑃 and Cramer’s 𝑉 values obtained for the effect of the belief
that natural remedies are safer than medicines were 0.000
and 0.345 and those obtained for the belief that “prescribers
place too much trust in medicines” on adherence were 0.006
(V = 0.570), respectively. The other beliefs of respondents
assessed had no effect on adherence to malaria medications
(Table 3).
3.5. Patients Demographics and Their Relationship to Adher-
ence. One hundred and sixty-three respondents (54%) were
males and 137 (45.4%) were females. Nine respondents (3%)
had no education, 150 (50%) had tertiary education, and 82
(27.2%) had senior high school education. The chi square
value obtained for the relationship between adherence and
patients’ age was 14.276 (df 8; 𝑃 = 0.075) while that obtained
for the relationship between adherence and educational level
of patients was 25.817 (df 12; 𝑃 = 0.011) (Table 4).
4. Discussion
AL was the most frequently antimalarial dispensed. In a sim-
ilar study in rural Tanzania, Artemether Lumefantrine (AL)
was the most common antimalarial dispensed from the drug
stores followed by sulfadoxine pyrimethamine, metakelfin,
amodiaquine, quinine, and chloroquine [18]. Although AL
was the antimalarial frequently dispensed, prescription pat-
tern varied from the results in our study. Currently in Ghana,
the ACTs are the only recommended medicines available for
uncomplicated malaria in nonpregnant adults and children.
Single therapies are not available [8]. AL obviously may
have become the drug of choice by most prescribers in
Ghana probably because AL andAA are the two antimalarials
supported by the AMFM initiative; hence they are readily
available and affordable. Secondly, prescribers in Ghana may
have preferred AL to AA because in 2005 there were reports
of adverse drug reaction to the AA combination which led to
the withdrawal of some preparations from the market; hence
prescribers currently may be reluctant to prescribe it [19].
Adherence level to the ACTs was 57.3%. In a similar study
in rural Kenya, adherence (assessed by pill count) to the
ACTs was 42.1% [11]. Percentage level of adherence obtained
is slightly higher than that obtained from the research in
Kenya. This could be because half (50.0%) of our sample
had education up to the tertiary level compared to the study
in Kenya which had a high proportion of the sample with
education up to the primary level. Considering the various
ACTs, adherence to AL was 61.6%. This result is similar to
studies in Malawi and two districts (Garissa and Bunyala) in
Kenya where adherence to AL was 65% and 64.1%, respec-
tively [10, 12]. Adherence to AA was 45%; the value is slightly
lower compared to a study in Sierra Leone where adherence
to AA was 57% [20]. The study in Sierra Leone was carried
out straightaway after the successful introduction of a new
malaria treatment and this may have affected the outcomes
of the study. After a new innovation, health professionals
renewed from training are highly motivated and are more
likely to pay attention to the information given to patients.
However, there is the need for interventions to increase the
level of adherence to the ACTs by hundred percent because
malaria is an acute infectious disease and the pathogens
are only killed when the full dose is taken. Subtherapeutic
dosages as a result of patients not completing their dosages
could lead to drug resistance, and this could alter the progress
made towards eradicating malaria in developing countries.
The Ghana Malaria Control Board in collaboration with
Pharmacy Council Ghana could adopt some interventions
that have been studied to enhance adherence to ACTs.
These include sending text message reminders to pharmacy
staff on the advice to give when dispensing ACTs and text
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Table 4: The relationship between adherence level and demographic characteristics.
Demographics Adherent Partially adherent Nonadherent 𝑃 value (𝑉)
Age
18–25 61 34 24
0.75 (0.154)
26–35 50 20 5
36–45 24 16 3
46–55 21 15 4
56 and above 16 4 3
Gender Male 93 49 21 0.986 (0.010)
Female 79 40 18
Educational level
No education 3 2 4
0.011 (0.207)
Primary 5 6 0
Middle school 5 6 0
JHS 16 15 6
SHS 48 25 9
Tertiary 95 35 20
message reminders on adherence to therapy within twelve-
hour intervals to patients [21].
The mean knowledge score on the causes, symptoms,
and prevention of malaria was 3.18 (SD = 0.852). This can
be attributed, to some extent, to the high level of malaria
education in the country. Despite very good knowledge on
the causes, signs, symptoms, and prevention of malaria,
this study also revealed evidence of knowledge gaps about
malaria by few respondents comparable to other studies [22,
23]. Considering the 𝑃 and Cramer’s 𝑉 values obtained for
the relationship between adherence to ACTs and patients’
knowledge with respect to causes, signs, symptoms, and
prevention of malaria, there was no significant relation-
ship.
The mean knowledge score on treatment of malaria was
4.0867 (SD = 1.069). More than 80.0% of our respondents
were of the view that the ACTs were effective and also knew
the name of the ACTs dispensed which was encouraging.
However, there were some knowledge gaps among respon-
dents. About 73.8% of respondents were of the view that the
ACTs were free of side effects. A significant and moderate
relationship was established between adherence and patients’
knowledge on the dosage of ACTprescribed.These results are
consistent with a similar study carried out in Kenya in which
patients’ knowledge of the dosing regimen was associated
with high adherence levels [12]. This underlines the need for
initiatives in community pharmacies to enhance counselling
on the dosage, effectiveness, and side effects of theACTswhen
they are dispensed. Education could be offered at the point of
care and educational materials could accompany medicines
dispensed. For patients who are illiterates, pictograms could
be used to ensure they understand the dosing regimen and
consequences of not completing their medicines. Further-
more, text messages could be sent to patients educating them
on the side effects of the ACTs and some precautionary
measures to be observed so as to minimize these side effects.
There is also the need for continuous education for all
pharmacy staff to sharpen their skills with regard to the
pharmaceutical care offered to patients with malaria, because
the community pharmacy is the first port of call of some
people with malaria.
Human beings have different beliefs and this can have
a significant impact on their behaviour. Thirty-four respon-
dents who agreed that prayers instead of medication healed
their malaria were partially adherent. These results are
consistent with others that highlight the essential role that
spiritual beliefs and practices play in understanding disease
in the African culture and the belief that God is ultimately
responsible for physical and spiritual health [24]. Significant
and moderate relationship was established between adher-
ence and some beliefs. Although people’s beliefs cannot be
changed easily, there is the need to consider the belief of
patients when care is offered as this can affect adherence to
the ACTs. For instance, the belief that “prescribers place too
much trust in medicines” could be addressed if community
pharmacists and staff use a concordance approach, where
the patient’s opinions and beliefs are considered when care
is offered. In addition, the belief that “natural remedies are
safer than medicines” and “people who take medicines can
stop their treatment for a while every now and then” could be
addressed when this approach is used.
The 𝑃 value obtained for the relationship between adher-
ence to ACTs and respondent’s educational level was 0.011
(Table 4). In a similar study in Uganda where pill count
was used to assess adherence, educational level was a factor
influencing adherence to ACTs but age was not associated
with adherence [25]. However, in a previous study in Kenya
both age and educational background of respondent were
found to be a significant predictor of adherence [11, 12].
There was no significant relationship between adherence and
gender of patients. A limitation to the study was that the
research was a nonrandomised single site study. Although the
participants in this study may reflect the sociodemographic
characteristics of malaria for patients in some parts of Accra,
they may not be representative of characteristics in other
geographical areas of Ghana. These limitations however did
not impact the results negatively.
5. Conclusion
Patient adherence level to the ACTs is moderate. In the
process of dispensing antimalarials, counseling should focus
Malaria Research and Treatment 7
more on the consequences of not completing antimalarial
doses, dosage, efficacy, and side effects of the antimalarials
and less on the causes, signs, symptoms, and prevention of
malaria. Furthermore patients’ beliefs and opinions should
consider when antimalarials are prescribed.
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